{"gene":"PHKB","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1989,"finding":"PHKB (beta subunit of phosphorylase kinase) was mapped to human chromosome 16q12-q13 by Southern blot analysis of somatic cell hybrid panels and in situ chromosomal hybridization, establishing it as an autosomal gene distinct from the X-linked alpha subunit (PHKA).","method":"Southern blot analysis of rodent x human somatic cell hybrid panels; in situ chromosomal hybridization","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — two orthogonal mapping methods, replicated across multiple somatic cell hybrid panels","pmids":["2757032"],"is_preprint":false},{"year":1996,"finding":"The human PHKB gene spans at least 140 kb, consists of 33 exons, and produces alternatively spliced isoforms: exons 26 and 27 are mutually exclusively spliced, and exon 2 is a facultative cassette exon encoding an alternative N-terminus. Two processed pseudogenes (PHKBP1, PHKBP2) were identified. The predicted protein is 95% identical in amino acid sequence to rabbit beta subunit.","method":"cDNA sequencing, genomic library screening, plaque hybridization, exon-intron boundary analysis","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct gene structure determination by cDNA and genomic sequencing with confirmation on chromosome 16-specific library","pmids":["8681948"],"is_preprint":false},{"year":1997,"finding":"Loss-of-function mutations in PHKB (nonsense, frameshift, splice-site, large deletion) cause autosomal glycogen storage disease affecting liver and muscle, confirming PHKB encodes the ubiquitous beta subunit required for phosphorylase kinase activity in these tissues.","method":"RT-PCR of patient blood RNA, direct Sanger sequencing of PCR products, genomic DNA PCR","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent mutations in multiple patients confirmed by both RNA and genomic analysis across independent families","pmids":["9215682"],"is_preprint":false},{"year":1997,"finding":"A missense mutation in PHKB (Ala117Pro) selectively impairs the interaction of phosphorylase kinase with the liver isoform of its substrate glycogen phosphorylase (measured by substrate-specific activity assay), while activity toward muscle phosphorylase added in vitro remains normal in leukocytes, demonstrating that the beta subunit contributes to substrate isoform recognition.","method":"RT-PCR mutation analysis, enzyme activity assay with different phosphorylase isoforms as substrates in patient blood cells","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single patient/single lab, but two orthogonal substrates used to dissect isoform-specific interaction","pmids":["9402963"],"is_preprint":false},{"year":1997,"finding":"Compound heterozygous loss-of-function mutations in PHKB (W609X and a splice-acceptor deletion causing premature stop) cause autosomal recessive liver phosphorylase kinase deficiency with severe hepatic enzyme reduction but only mild erythrocyte involvement, confirming the beta subunit is required for normal hepatic phosphorylase kinase activity.","method":"RT-PCR, SSCP analysis, genomic DNA sequencing, family segregation analysis","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal mutation-detection methods, family segregation confirms pathogenicity","pmids":["9326319"],"is_preprint":false},{"year":2014,"finding":"PHKB (glycogen phosphorylase kinase beta subunit) physically interacts with the C-terminal region of KIAA1199 protein, as shown by pull-down assay; this interaction, together with a secondary KIAA1199–glycogen phosphorylase brain form (PYGB) interaction under serum-free conditions, promotes glycogen breakdown and cancer cell survival.","method":"Pull-down assay with KIAA1199-MBP fusion protein; retroviral overexpression of KIAA1199 in cancer cell lines; glycogen breakdown and cell survival readouts","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct pull-down identifies PHKB as binding partner; functional consequence shown in cell lines with multiple readouts, single lab","pmids":["25051373"],"is_preprint":false},{"year":2022,"finding":"Phkb knockout mice (Phkb−/−) show hepatomegaly, reduced fasting blood glucose, only partial liver glycogen phosphorylase activity, and increased sensitivity to pyruvate, demonstrating that Phkb is required for full activation of the liver isoform of glycogen phosphorylase (PYGL) during glycogenolysis; compensatory upregulation of gluconeogenesis and lipid metabolism was also observed.","method":"Phkb knockout mouse model; fasting blood glucose and ketone measurement; glycogen phosphorylase activity assay; pyruvate tolerance test; gene expression analysis; liver histology","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO mouse with multiple orthogonal metabolic and biochemical readouts establishing specific role in glycogenolysis","pmids":["36077341"],"is_preprint":false}],"current_model":"PHKB encodes the ubiquitously expressed beta subunit of phosphorylase kinase (PhK), a hetero-16-mer (αβγδ)4; it maps to chromosome 16q12-q13, is expressed from a 33-exon gene with alternative splicing of exons 2, 26/27, contributes to substrate (glycogen phosphorylase) isoform recognition via its Ala117 region, is required for full activation of the liver glycogen phosphorylase (PYGL) during glycogenolysis in vivo, and physically interacts with KIAA1199 to promote glycogen breakdown; loss-of-function mutations cause autosomal recessive GSD-IX-beta."},"narrative":{"mechanistic_narrative":"PHKB encodes the ubiquitously expressed beta subunit of phosphorylase kinase, the multimeric enzyme that activates glycogen phosphorylase to initiate glycogenolysis [PMID:9215682, PMID:36077341]. The gene maps to chromosome 16q12-q13, distinguishing it from the X-linked alpha subunit, and is expressed from a 33-exon gene with alternatively spliced isoforms (mutually exclusive exons 26/27 and a facultative exon 2 encoding an alternative N-terminus) [PMID:2757032, PMID:8681948]. Beyond its structural role in the holoenzyme, the beta subunit contributes to substrate isoform recognition: an Ala117Pro substitution selectively impairs phosphorylase kinase activity toward the liver phosphorylase isoform while leaving muscle phosphorylase activity intact [PMID:9402963]. Phkb-knockout mice exhibit hepatomegaly, reduced fasting blood glucose, and only partial liver glycogen phosphorylase (PYGL) activity, establishing that the beta subunit is required for full activation of the liver phosphorylase isoform during glycogenolysis, with compensatory upregulation of gluconeogenesis and lipid metabolism [PMID:36077341]. PHKB also physically engages the C-terminal region of KIAA1199, a interaction linked to glycogen breakdown and cancer cell survival [PMID:25051373]. Loss-of-function mutations (nonsense, frameshift, splice-site, and large deletions) cause autosomal recessive glycogen storage disease affecting liver and muscle (GSD-IX-beta) [PMID:9215682, PMID:9326319].","teleology":[{"year":1989,"claim":"Establishing that the beta subunit is encoded by an autosomal gene distinct from the X-linked alpha subunit defined the genetic architecture underlying tissue-specific and inheritance-pattern differences in phosphorylase kinase deficiency.","evidence":"Southern blot of rodent x human somatic cell hybrid panels and in situ chromosomal hybridization localizing PHKB to 16q12-q13","pmids":["2757032"],"confidence":"High","gaps":["Chromosomal assignment alone does not define gene structure or protein function","Does not address how the subunit assembles into the holoenzyme"]},{"year":1996,"claim":"Determining the full PHKB gene structure and alternative splicing pattern provided the molecular framework needed to interpret mutations and isoform diversity.","evidence":"cDNA and genomic sequencing, library screening, and exon-intron boundary analysis defining 33 exons, mutually exclusive exons 26/27, and facultative exon 2","pmids":["8681948"],"confidence":"High","gaps":["Functional consequences of the spliced isoforms not established","No structural model of the subunit within the holoenzyme"]},{"year":1997,"claim":"Identifying loss-of-function mutations across liver and muscle confirmed that PHKB encodes the ubiquitous beta subunit required for phosphorylase kinase activity and established it as the cause of an autosomal glycogen storage disease.","evidence":"RT-PCR and genomic sequencing of patients revealing nonsense, frameshift, splice-site, and deletion mutations across independent families, including compound heterozygous W609X and a splice-acceptor deletion","pmids":["9215682","9326319"],"confidence":"High","gaps":["Why hepatic involvement is severe while erythrocyte/muscle involvement is mild is not mechanistically resolved","Genotype-phenotype relationships across mutation classes incompletely mapped"]},{"year":1997,"claim":"A point mutation that selectively impaired activity toward liver but not muscle phosphorylase showed that the beta subunit itself contributes to substrate isoform recognition, not merely structural assembly.","evidence":"RT-PCR mutation analysis plus enzyme activity assays using liver versus muscle phosphorylase isoforms as substrates in patient leukocytes (Ala117Pro)","pmids":["9402963"],"confidence":"Medium","gaps":["Single patient/single lab observation","Structural basis of the Ala117 region's isoform discrimination not defined"]},{"year":2014,"claim":"Discovery of a physical PHKB-KIAA1199 interaction extended the beta subunit's relevance beyond classical glycogenolysis to a glycogen-breakdown axis supporting cancer cell survival.","evidence":"Pull-down assay with KIAA1199-MBP fusion and retroviral overexpression in cancer cell lines with glycogen breakdown and survival readouts","pmids":["25051373"],"confidence":"Medium","gaps":["Single lab without reciprocal validation in primary tissue","Whether the interaction modulates holoenzyme activity directly is unknown"]},{"year":2022,"claim":"A knockout mouse demonstrated in vivo that the beta subunit is required for full activation of liver phosphorylase during glycogenolysis, with metabolic compensation revealing systemic consequences of beta-subunit loss.","evidence":"Phkb-/- mice analyzed by fasting glucose/ketone measurement, glycogen phosphorylase activity assay, pyruvate tolerance test, expression analysis, and liver histology","pmids":["36077341"],"confidence":"High","gaps":["Residual partial phosphorylase activity in the absence of beta subunit is unexplained","Mechanism of compensatory gluconeogenesis/lipid upregulation not dissected"]},{"year":null,"claim":"The structural basis for how the beta subunit confers substrate isoform recognition and regulates holoenzyme activation remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of PHKB within the (alpha-beta-gamma-delta)4 holoenzyme","Functional roles of the alternatively spliced isoforms uncharacterized","Physiological significance of the KIAA1199 interaction in normal tissue not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,6]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,6]}],"complexes":["phosphorylase kinase"],"partners":["KIAA1199","PYGL"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q93100","full_name":"Phosphorylase b kinase regulatory subunit beta","aliases":[],"length_aa":1093,"mass_kda":124.9,"function":"Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The beta chain acts as a regulatory unit and modulates the activity of the holoenzyme in response to phosphorylation","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q93100/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PHKB","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PHKG2","stoichiometry":10.0},{"gene":"CALM1","stoichiometry":0.2},{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PHKB","total_profiled":1310},"omim":[{"mim_id":"611556","title":"GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B","url":"https://www.omim.org/entry/611556"},{"mim_id":"311870","title":"PHOSPHORYLASE KINASE, MUSCLE, ALPHA-1 SUBUNIT; PHKA1","url":"https://www.omim.org/entry/311870"},{"mim_id":"306000","title":"GLYCOGEN STORAGE DISEASE IXa1; GSD9A1","url":"https://www.omim.org/entry/306000"},{"mim_id":"300798","title":"PHOSPHORYLASE KINASE, LIVER, ALPHA-2 SUBUNIT; PHKA2","url":"https://www.omim.org/entry/300798"},{"mim_id":"300559","title":"GLYCOGEN STORAGE DISEASE IXd; GSD9D","url":"https://www.omim.org/entry/300559"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":122.8}],"url":"https://www.proteinatlas.org/search/PHKB"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q93100","domains":[{"cath_id":"1.50.10.10","chopping":"44-462","consensus_level":"medium","plddt":93.9529,"start":44,"end":462},{"cath_id":"-","chopping":"494-671","consensus_level":"high","plddt":89.8046,"start":494,"end":671},{"cath_id":"-","chopping":"715-788","consensus_level":"high","plddt":91.243,"start":715,"end":788},{"cath_id":"-","chopping":"792-916","consensus_level":"medium","plddt":89.309,"start":792,"end":916},{"cath_id":"-","chopping":"939-1085","consensus_level":"medium","plddt":89.4179,"start":939,"end":1085}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q93100","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q93100-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q93100-F1-predicted_aligned_error_v6.png","plddt_mean":86.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PHKB","jax_strain_url":"https://www.jax.org/strain/search?query=PHKB"},"sequence":{"accession":"Q93100","fasta_url":"https://rest.uniprot.org/uniprotkb/Q93100.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q93100/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q93100"}},"corpus_meta":[{"pmid":"9215682","id":"PMC_9215682","title":"Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB).","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9215682","citation_count":62,"is_preprint":false},{"pmid":"2757032","id":"PMC_2757032","title":"Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12-q13 and beta (PHKB) to 16q12-q13.","date":"1989","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2757032","citation_count":59,"is_preprint":false},{"pmid":"25051373","id":"PMC_25051373","title":"KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25051373","citation_count":44,"is_preprint":false},{"pmid":"9402963","id":"PMC_9402963","title":"Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB).","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9402963","citation_count":31,"is_preprint":false},{"pmid":"9326319","id":"PMC_9326319","title":"Autosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB).","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9326319","citation_count":26,"is_preprint":false},{"pmid":"38287405","id":"PMC_38287405","title":"Circ-phkb promotes cell apoptosis and inflammation in LPS-induced alveolar macrophages via the TLR4/MyD88/NF-kB/CCL2 axis.","date":"2024","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/38287405","citation_count":21,"is_preprint":false},{"pmid":"8681948","id":"PMC_8681948","title":"Structure of the human gene encoding the phosphorylase kinase beta subunit (PHKB).","date":"1996","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8681948","citation_count":19,"is_preprint":false},{"pmid":"31891018","id":"PMC_31891018","title":"A novel enhancer RNA, Hmrhl, positively regulates its host gene, phkb, in chronic myelogenous leukemia.","date":"2019","source":"Non-coding RNA research","url":"https://pubmed.ncbi.nlm.nih.gov/31891018","citation_count":11,"is_preprint":false},{"pmid":"36077341","id":"PMC_36077341","title":"A Mouse Model of Glycogen Storage Disease Type IX-Beta: A Role for Phkb in Glycogenolysis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36077341","citation_count":9,"is_preprint":false},{"pmid":"33858366","id":"PMC_33858366","title":"Novel mutations in the PHKB gene in an iranian girl with severe liver involvement and glycogen storage disease type IX: a case report and review of literature.","date":"2021","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/33858366","citation_count":6,"is_preprint":false},{"pmid":"1424811","id":"PMC_1424811","title":"Assignment of the rabbit genes for alpha (PHKA) and beta (PHKB) phosphorylase kinase subunits.","date":"1992","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1424811","citation_count":5,"is_preprint":false},{"pmid":"40054808","id":"PMC_40054808","title":"Effects of circPICALM-miR-132-PHKB regulated by METTL3 on proliferation of porcine skeletal muscle satellite cells.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40054808","citation_count":1,"is_preprint":false},{"pmid":"39188489","id":"PMC_39188489","title":"Glycogen Storage Disorder Type IXb: Exploring Clinical Patterns and Genetic Insights Into a Rare Phosphorylase Kinase B (PHKB)-Associated Case.","date":"2024","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/39188489","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.04.25337324","title":"Integrated Bioinformatics and Pharmacogenomic Profiling of a Gene Panel in Diabetes Mellitus Treatment Response","date":"2025-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.04.25337324","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8848,"output_tokens":1756,"usd":0.026442,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8698,"output_tokens":2412,"usd":0.051895,"stage2_stop_reason":"end_turn"},"total_usd":0.078337,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"PHKB (beta subunit of phosphorylase kinase) was mapped to human chromosome 16q12-q13 by Southern blot analysis of somatic cell hybrid panels and in situ chromosomal hybridization, establishing it as an autosomal gene distinct from the X-linked alpha subunit (PHKA).\",\n      \"method\": \"Southern blot analysis of rodent x human somatic cell hybrid panels; in situ chromosomal hybridization\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two orthogonal mapping methods, replicated across multiple somatic cell hybrid panels\",\n      \"pmids\": [\"2757032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The human PHKB gene spans at least 140 kb, consists of 33 exons, and produces alternatively spliced isoforms: exons 26 and 27 are mutually exclusively spliced, and exon 2 is a facultative cassette exon encoding an alternative N-terminus. Two processed pseudogenes (PHKBP1, PHKBP2) were identified. The predicted protein is 95% identical in amino acid sequence to rabbit beta subunit.\",\n      \"method\": \"cDNA sequencing, genomic library screening, plaque hybridization, exon-intron boundary analysis\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct gene structure determination by cDNA and genomic sequencing with confirmation on chromosome 16-specific library\",\n      \"pmids\": [\"8681948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Loss-of-function mutations in PHKB (nonsense, frameshift, splice-site, large deletion) cause autosomal glycogen storage disease affecting liver and muscle, confirming PHKB encodes the ubiquitous beta subunit required for phosphorylase kinase activity in these tissues.\",\n      \"method\": \"RT-PCR of patient blood RNA, direct Sanger sequencing of PCR products, genomic DNA PCR\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent mutations in multiple patients confirmed by both RNA and genomic analysis across independent families\",\n      \"pmids\": [\"9215682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"A missense mutation in PHKB (Ala117Pro) selectively impairs the interaction of phosphorylase kinase with the liver isoform of its substrate glycogen phosphorylase (measured by substrate-specific activity assay), while activity toward muscle phosphorylase added in vitro remains normal in leukocytes, demonstrating that the beta subunit contributes to substrate isoform recognition.\",\n      \"method\": \"RT-PCR mutation analysis, enzyme activity assay with different phosphorylase isoforms as substrates in patient blood cells\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single patient/single lab, but two orthogonal substrates used to dissect isoform-specific interaction\",\n      \"pmids\": [\"9402963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Compound heterozygous loss-of-function mutations in PHKB (W609X and a splice-acceptor deletion causing premature stop) cause autosomal recessive liver phosphorylase kinase deficiency with severe hepatic enzyme reduction but only mild erythrocyte involvement, confirming the beta subunit is required for normal hepatic phosphorylase kinase activity.\",\n      \"method\": \"RT-PCR, SSCP analysis, genomic DNA sequencing, family segregation analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal mutation-detection methods, family segregation confirms pathogenicity\",\n      \"pmids\": [\"9326319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PHKB (glycogen phosphorylase kinase beta subunit) physically interacts with the C-terminal region of KIAA1199 protein, as shown by pull-down assay; this interaction, together with a secondary KIAA1199–glycogen phosphorylase brain form (PYGB) interaction under serum-free conditions, promotes glycogen breakdown and cancer cell survival.\",\n      \"method\": \"Pull-down assay with KIAA1199-MBP fusion protein; retroviral overexpression of KIAA1199 in cancer cell lines; glycogen breakdown and cell survival readouts\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct pull-down identifies PHKB as binding partner; functional consequence shown in cell lines with multiple readouts, single lab\",\n      \"pmids\": [\"25051373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Phkb knockout mice (Phkb−/−) show hepatomegaly, reduced fasting blood glucose, only partial liver glycogen phosphorylase activity, and increased sensitivity to pyruvate, demonstrating that Phkb is required for full activation of the liver isoform of glycogen phosphorylase (PYGL) during glycogenolysis; compensatory upregulation of gluconeogenesis and lipid metabolism was also observed.\",\n      \"method\": \"Phkb knockout mouse model; fasting blood glucose and ketone measurement; glycogen phosphorylase activity assay; pyruvate tolerance test; gene expression analysis; liver histology\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO mouse with multiple orthogonal metabolic and biochemical readouts establishing specific role in glycogenolysis\",\n      \"pmids\": [\"36077341\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PHKB encodes the ubiquitously expressed beta subunit of phosphorylase kinase (PhK), a hetero-16-mer (αβγδ)4; it maps to chromosome 16q12-q13, is expressed from a 33-exon gene with alternative splicing of exons 2, 26/27, contributes to substrate (glycogen phosphorylase) isoform recognition via its Ala117 region, is required for full activation of the liver glycogen phosphorylase (PYGL) during glycogenolysis in vivo, and physically interacts with KIAA1199 to promote glycogen breakdown; loss-of-function mutations cause autosomal recessive GSD-IX-beta.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PHKB encodes the ubiquitously expressed beta subunit of phosphorylase kinase, the multimeric enzyme that activates glycogen phosphorylase to initiate glycogenolysis [#2, #6]. The gene maps to chromosome 16q12-q13, distinguishing it from the X-linked alpha subunit, and is expressed from a 33-exon gene with alternatively spliced isoforms (mutually exclusive exons 26/27 and a facultative exon 2 encoding an alternative N-terminus) [#0, #1]. Beyond its structural role in the holoenzyme, the beta subunit contributes to substrate isoform recognition: an Ala117Pro substitution selectively impairs phosphorylase kinase activity toward the liver phosphorylase isoform while leaving muscle phosphorylase activity intact [#3]. Phkb-knockout mice exhibit hepatomegaly, reduced fasting blood glucose, and only partial liver glycogen phosphorylase (PYGL) activity, establishing that the beta subunit is required for full activation of the liver phosphorylase isoform during glycogenolysis, with compensatory upregulation of gluconeogenesis and lipid metabolism [#6]. PHKB also physically engages the C-terminal region of KIAA1199, a interaction linked to glycogen breakdown and cancer cell survival [#5]. Loss-of-function mutations (nonsense, frameshift, splice-site, and large deletions) cause autosomal recessive glycogen storage disease affecting liver and muscle (GSD-IX-beta) [#2, #4].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Establishing that the beta subunit is encoded by an autosomal gene distinct from the X-linked alpha subunit defined the genetic architecture underlying tissue-specific and inheritance-pattern differences in phosphorylase kinase deficiency.\",\n      \"evidence\": \"Southern blot of rodent x human somatic cell hybrid panels and in situ chromosomal hybridization localizing PHKB to 16q12-q13\",\n      \"pmids\": [\"2757032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromosomal assignment alone does not define gene structure or protein function\", \"Does not address how the subunit assembles into the holoenzyme\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Determining the full PHKB gene structure and alternative splicing pattern provided the molecular framework needed to interpret mutations and isoform diversity.\",\n      \"evidence\": \"cDNA and genomic sequencing, library screening, and exon-intron boundary analysis defining 33 exons, mutually exclusive exons 26/27, and facultative exon 2\",\n      \"pmids\": [\"8681948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of the spliced isoforms not established\", \"No structural model of the subunit within the holoenzyme\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identifying loss-of-function mutations across liver and muscle confirmed that PHKB encodes the ubiquitous beta subunit required for phosphorylase kinase activity and established it as the cause of an autosomal glycogen storage disease.\",\n      \"evidence\": \"RT-PCR and genomic sequencing of patients revealing nonsense, frameshift, splice-site, and deletion mutations across independent families, including compound heterozygous W609X and a splice-acceptor deletion\",\n      \"pmids\": [\"9215682\", \"9326319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why hepatic involvement is severe while erythrocyte/muscle involvement is mild is not mechanistically resolved\", \"Genotype-phenotype relationships across mutation classes incompletely mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"A point mutation that selectively impaired activity toward liver but not muscle phosphorylase showed that the beta subunit itself contributes to substrate isoform recognition, not merely structural assembly.\",\n      \"evidence\": \"RT-PCR mutation analysis plus enzyme activity assays using liver versus muscle phosphorylase isoforms as substrates in patient leukocytes (Ala117Pro)\",\n      \"pmids\": [\"9402963\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient/single lab observation\", \"Structural basis of the Ala117 region's isoform discrimination not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery of a physical PHKB-KIAA1199 interaction extended the beta subunit's relevance beyond classical glycogenolysis to a glycogen-breakdown axis supporting cancer cell survival.\",\n      \"evidence\": \"Pull-down assay with KIAA1199-MBP fusion and retroviral overexpression in cancer cell lines with glycogen breakdown and survival readouts\",\n      \"pmids\": [\"25051373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab without reciprocal validation in primary tissue\", \"Whether the interaction modulates holoenzyme activity directly is unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A knockout mouse demonstrated in vivo that the beta subunit is required for full activation of liver phosphorylase during glycogenolysis, with metabolic compensation revealing systemic consequences of beta-subunit loss.\",\n      \"evidence\": \"Phkb-/- mice analyzed by fasting glucose/ketone measurement, glycogen phosphorylase activity assay, pyruvate tolerance test, expression analysis, and liver histology\",\n      \"pmids\": [\"36077341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residual partial phosphorylase activity in the absence of beta subunit is unexplained\", \"Mechanism of compensatory gluconeogenesis/lipid upregulation not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for how the beta subunit confers substrate isoform recognition and regulates holoenzyme activation remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of PHKB within the (alpha-beta-gamma-delta)4 holoenzyme\", \"Functional roles of the alternatively spliced isoforms uncharacterized\", \"Physiological significance of the KIAA1199 interaction in normal tissue not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 6]}\n    ],\n    \"complexes\": [\"phosphorylase kinase\"],\n    \"partners\": [\"KIAA1199\", \"PYGL\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}